260 related articles for article (PubMed ID: 24258773)
1. Pharmacokinetics and pharmacodynamics of famotidine and ranitidine in critically ill children.
Madani S; Kauffman R; Simpson P; Lehr VT; Lai ML; Sarniak A; Tolia V
J Clin Pharmacol; 2014 Feb; 54(2):201-5. PubMed ID: 24258773
[TBL] [Abstract][Full Text] [Related]
2. A controlled comparison of continuous ranitidine and intermittent famotidine infusions on gastric pH.
Bachmann K; Sullivan TJ; Jauregui L
J Clin Pharmacol; 1993 Dec; 33(12):1219-24. PubMed ID: 7907348
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of ranitidine and famotidine in healthy elderly subjects: a double-blind, placebo-controlled comparison.
Bisson C; St-Laurent M; Michaud JT; LeBel M
Pharmacotherapy; 1993; 13(1):3-9. PubMed ID: 8437966
[TBL] [Abstract][Full Text] [Related]
4. A randomized clinical trial comparing the efficacy of ranitidine and famotidine on intragastric acidity in critically ill pediatric patients.
Aanpreung P; Vanprapar N; Susiva C; Parkpreaw C; Boonyachart C
J Med Assoc Thai; 1998 Mar; 81(3):185-9. PubMed ID: 9623009
[TBL] [Abstract][Full Text] [Related]
5. Effects of two dosing regimens of intravenous ranitidine on gastric pH in critically ill children.
Osteyee JL; Banner W
Am J Crit Care; 1994 Jul; 3(4):267-72. PubMed ID: 7920954
[TBL] [Abstract][Full Text] [Related]
6. Early and late effects of low-dose famotidine, ranitidine or placebo on pentagastrin-stimulated gastric acid secretion in man.
Grimley CE; West JM; Loft DE; Cottrell J; Mann SG; Stauffer L; Nwokolo CU
Aliment Pharmacol Ther; 1996 Oct; 10(5):743-7. PubMed ID: 8899082
[TBL] [Abstract][Full Text] [Related]
7. Gastric acid suppression is greater during intravenous ranitidine infusion versus bolus injections of famotidine.
Hogan DL; McQuaid KR; Koss MA; Crombie DL; Hunter S; Metz C; Euler AR; Isenberg JI
Aliment Pharmacol Ther; 1993 Oct; 7(5):537-41. PubMed ID: 8280822
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of famotidine in children.
James LP; Marshall JD; Heulitt MJ; Wells TG; Letzig L; Kearns GL
J Clin Pharmacol; 1996 Jan; 36(1):48-54. PubMed ID: 8932543
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
Lugo RA; Harrison AM; Cash J; Sweeley J; Vernon DD
Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
11. Effects of different combinations of H2 receptor antagonist with gastrokinetic drugs on gastric fluid pH and volume in children--a comparative study.
Kulkarni PN; Batra YK; Wig J
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):561-4. PubMed ID: 9455714
[TBL] [Abstract][Full Text] [Related]
12. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effect of the antacid Rennie versus low-dose H2-receptor antagonists (ranitidine, famotidine) on intragastric acidity.
Netzer P; Brabetz-Höfliger A; Bründler R; Flogerzi B; Hüsler J; Halter F
Aliment Pharmacol Ther; 1998 Apr; 12(4):337-42. PubMed ID: 9690722
[TBL] [Abstract][Full Text] [Related]
14. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of famotidine in infants.
James LP; Marotti T; Stowe CD; Farrar HC; Taylor BJ; Kearns GL
J Clin Pharmacol; 1998 Dec; 38(12):1089-95. PubMed ID: 11301560
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic modeling of the acid inhibitory effect of ranitidine in patients in an intensive care unit during prolonged dosing: characterization of tolerance.
Mathôt RA; Geus WP
Clin Pharmacol Ther; 1999 Aug; 66(2):140-51. PubMed ID: 10460068
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of bolus famotidine versus infused cimetidine, ranitidine, and famotidine.
Amsden GW; Goss TF; Harrison NJ; D'Andrea DT; Schentag JJ
J Clin Pharmacol; 1994 Dec; 34(12):1191-8. PubMed ID: 7738215
[TBL] [Abstract][Full Text] [Related]
18. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
Reilly TG; Singh S; Cottrell J; Mann SG; Stauffer L; Walt RP
Aliment Pharmacol Ther; 1996 Oct; 10(5):749-55. PubMed ID: 8899083
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
Lachman L; Howden CW
Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
[TBL] [Abstract][Full Text] [Related]
20. Determination of the time of onset of action of ranitidine and famotidine on intra-gastric acidity.
Gardner JD; Ciociola AA; Robinson M; McIsaac RL
Aliment Pharmacol Ther; 2002 Jul; 16(7):1317-26. PubMed ID: 12144582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
